Uber Just Reinvented the Bus … Again
Beyond the jokes about its new shuttle service are serious questions about what it will mean for struggling transit systems, air quality, and congestion.
Blocked From Selling Off-Brand Ozempic, Telehealth Startups Embrace a Less Effective Drug
As the FDA halts the sale of Ozempic and Zepbound copycats, online clinics have begun offering liraglutide, an older GLP-1 medication injected daily instead of weekly.
The Future of Manufacturing Might Be in Space
Products made in space—and used on Earth—could be a reality in the coming years.
The Dream of the Metaverse Is Dying. Manufacturing Is Keeping It Alive
Forget Mark Zuckerberg’s vision of VR meetings; the industrial metaverse bridges digital and physical worlds in a way that’s actually useful.
The Climate Crisis Threatens Supply Chains. Manufacturers Hope AI Can Help
The Covid-19 pandemic showed just how vulnerable global supply chains are. Climate shocks could pose an even greater risk.
2025 Is the Year of the Humanoid Robot Factory Worker
Long confined to the lab, humanoids finally appear ready to work in manufacturing. There are just a few hurdles to get them to market.
The Agonizing Task of Turning Europe’s Power Back On
A massive blackout affecting Spain, Portugal, and parts of France has been blamed on atmospheric conditions. Now engineers face the arduous task of getting the power back on.
Eli Lilly Sues 4 GLP-1 Telehealth Startups, Escalating War on Knockoff Drugs
Pharmaceutical giant Eli Lilly alleges the companies are selling off-brand versions of its best-selling diabetes and weight-loss drugs, Mounjaro and Zepbound.
Thousands of Urine and Tissue Samples Are in Danger of Rotting After Staff Cuts at a CDC Laboratory
Workers who recently lost their jobs at the National Institute for Occupational Safety say they’re concerned that there’s no plan for managing biological samples tied to research projects.
This Startup Says It Can Clean Your Blood of Microplastics
The elective medical industry is cashing in on plastic pollution fears, but the evidence of harm from microplastics is still deeply uncertain.